NEUROCRINE BIOSCIENCES INC Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEUROCRINE BIOSCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEUROCRINE BIOSCIENCES INC for February 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 25 2015 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Option Exercise | M | 5.76 | 20,000 | 115,200 | 65,000 | |
Feb 25 2015 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Sell | S | 40.00 | 20,000 | 800,000 | 80,308 | 100.3 K to 80.3 K (-19.94 %) |
Feb 25 2015 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Buy | M | 5.76 | 20,000 | 115,200 | 100,308 | 80.3 K to 100.3 K (+24.90 %) |
Feb 11 2015 | NBIX | NEUROCRINE BIOSCIE ... | LYONS GARY A | Director | Option Exercise | M | 4.76 | 7,500 | 35,700 | 0 | |
Feb 11 2015 | NBIX | NEUROCRINE BIOSCIE ... | LYONS GARY A | Director | Payment of Exercise | F | 35.83 | 996 | 35,687 | 297,066 | 298.1 K to 297.1 K (-0.33 %) |
Feb 11 2015 | NBIX | NEUROCRINE BIOSCIE ... | LYONS GARY A | Director | Buy | M | 4.76 | 7,500 | 35,700 | 298,062 | 290.6 K to 298.1 K (+2.58 %) |
Feb 11 2015 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Option Exercise | M | 5.76 | 20,000 | 115,200 | 85,000 | |
Feb 11 2015 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Sell | S | 35.00 | 20,000 | 700,000 | 80,308 | 100.3 K to 80.3 K (-19.94 %) |
Feb 11 2015 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Buy | M | 5.76 | 20,000 | 115,200 | 100,308 | 80.3 K to 100.3 K (+24.90 %) |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | President and CEO | Option Exercise | A | 32.99 | 150,000 | 4,948,500 | 150,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | President and CEO | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | A | 32.99 | 80,000 | 2,639,200 | 80,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | OBrien Christopher Flint | Chief Medical Offic ... | Option Exercise | A | 32.99 | 75,000 | 2,474,250 | 75,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | OBrien Christopher Flint | Chief Medical Offic ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 32.99 | 65,000 | 2,144,350 | 65,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Option Exercise | A | 32.99 | 65,000 | 2,144,350 | 65,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Gano Kyle | Chief Business Dev ... | Option Exercise | A | 32.99 | 65,000 | 2,144,350 | 65,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Gano Kyle | Chief Business Dev ... | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 32.99 | 30,000 | 989,700 | 30,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Lloyd-Smith Malcolm | Chief Regulatory Of ... | Option Exercise | A | 32.99 | 22,000 | 725,780 | 22,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Lloyd-Smith Malcolm | Chief Regulatory Of ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 |